Schedule 13D ownership disclosure
PASSAGE BIO INC
COMMON STOCK · CUSIP: 702712100
Event date: 2025-07-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 132,473.00 · Class: 4.25%
- ORBIMED CAPITAL GP VII LLCReported CIK 0001760648
Shares: 132,473.00 · Class: 4.25%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000684
- Form type
- SCHEDULE 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Jul 24, 2025
- Reporting period
- Jul 22, 2025
- Description
- Schedule 13D beneficial ownership